Altimmune Newsroom

Altimmune Shares Surge on CEO's CNBC Appearance

InvestingDec 4 11:18 ET

Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday

BenzingaDec 4 10:55 ET

Altimmune Stock Up More Than 25% in a Month: Here's Why

BarchartDec 2 10:38 ET

Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders

GlobeNewswireDec 2 07:30 ET

Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.

Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.

Zhitong FinanceNov 26 08:38 ET

Altimmune to Participate at Two Upcoming Investor Conferences

GlobeNewswireNov 26 07:30 ET

White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs

WSJNov 26 05:37 ET

Trump Nominates Marty Makary For FDA Commissioner

Barron'sNov 22 22:27 ET

Executive Reshuffles: TWO, CYBR, PFG and ALT

Seeking AlphaNov 16 15:54 ET

Altimmune Presents New Data On The Effect Of Pemvidutide On Inflammatory Lipids In Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease At The Liver Meeting 2024

BenzingaNov 15 11:01 ET

Altimmune Third Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceNov 14 06:15 ET

Eli Lilly and Co. is startled, novo-nordisk a/s saves the day! The market prospects for weight loss drugs still tempt many players.

The weight loss drug market still has a broad prospect, with most institutions predicting that the market size will reach the trillion-dollar level by the end of this decade.

Zhitong FinanceNov 14 01:45 ET

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaNov 13 12:35 ET

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsNov 13 11:31 ET · Ratings

Altimmune Call Volume Above Normal and Directionally Bullish

TipRanksNov 13 11:25 ET

Altimmune Provided Key Pipeline Updates With Q3 Report, Says B. Riley

TipRanksNov 13 11:20 ET

Altimmune's Pemvidutide Progress and Expansion: A Buy Recommendation by Patrick Trucchio

TipRanksNov 13 11:05 ET · Ratings

Altimmune's Pemvidutide Looks Differentiated Among GLP-1s, Says H.C. Wainwright

TipRanksNov 13 11:00 ET

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 13 09:33 ET · Ratings

Altimmune (ALT) Receives a Buy From Evercore ISI

TipRanksNov 13 08:37 ET · Ratings